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Abstract
FREQUENCY OF TLR-2, 4, 9 AND CD14 POLYMORPHISMS IN AGGRESSIVE 
PERIODONTITIS POPULATION IN AFRICAN-AMERICANS
By Melanie Chou, D.M.D.
A thesis submitted in partial fulfillment of the requirements for the degree of MSD at 
Virginia Commonwealth University.
Virginia Commonwealth University, 2009
Major Director:  Esra Sahingur, D.D.S., M.S.
Associate Professor, Department of Periodontics
Aim: The aim of this study is to determine the frequency of single nucleotide 
polymorphisms (SNPs) in various pattern recognition receptor (PRR) genes, including Toll 
like receptors (TLR) -2, -4, -9, and CD14 in chronic (CP), localized (LAP) and generalized 
aggressive (GAP) periodontitis and periodontally healthy (NP) patients in an African 
American population. Methods: A total of 205 subjects were involved in the study. The 
LAP group consists of 25 subjects, the GAP group 50 subjects, the CP group 73 subjects 
and the NP group 57subjects. Genotyping was performed in TLR2 (G2408A), TLR4 
(A896G),TLR9 (T1486C) and CD14 (C260T)  genes by TaqMan® allelic discrimination 
vii
using Assay-by-DesignSM SNP Genotyping Assays (Applied Biosystems). Accuracy of 
genotyping was confirmed by known DNA samples of each genotype and by Polymerase 
Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) analyses on 
selected samples. Fisher’s exact test and chi-square analyses were performed to compare 
genotype and allele frequencies. Within disease groups, we investigated whether SNPs 
were related to disease severity by step-wise logistic regression adjusted for age, gender, 
and smoking status. Results: There was a significant difference in the distribution of 
specific TLR9 (T1486C) genotypes between diseased-groups versus reference group. 
Expression of TT genotype was more prevelant in periodontally-diseased individuals 
compared to periodontally-healthy subjects (p<0.0001) whereas individuals expressing C 
allele of the TLR9 SNP (CC&CT) were more frequently found in healthy group after 
adjusting for age, gender, and smoking status (p<0.0001) There was no statistically 
significant difference in the distribution of genotypes between groups for any other TLRs 
or CD 14 polymorphism. Conclusion: Based on findings of this study, homozygocity for 
the T allele of TLR 9 polymorphism was related to the periodontal disease susceptibility in 
African Americans. Additionally, presence of C allele at TLR-9 appeared to confer 
resistance to periodontal destruction.  Our results showed that specific SNPs in TLR-2, -4 
and CD 14 genes are not related to periodontitis in African Americans. However, low copy 
number of certain alleles warrants further investigations with increased sample size to 
explore the role of SNPs in periodontal disease. 
This study was supported by the Alexander Fellowship.
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CHAPTER 1 Introduction
The objective of this study is to determine the frequency of TLR-2, 4, and 9 and 
CD 14 polymorphisms in aggressive periodontitis and periodontally healthy patients in an 
African-American population
Aggressive  periodontitis  (AgP)  is  a  rare  but  severe  and  progressive  form  of 
periodontal disease in otherwise healthy patients. It is characterized by a rapid destruction 
of periodontal tissue, and familial aggregation is considered.1 There is considerable interest 
in studies aimed at understanding its etiology and pathogenesis although it is a relatively 
rare disorder (0.1-5%).2 Literature has shown that AgP is caused by multiple potential risk 
factors. Previous studies implicated that the presence of pathogenic biofilm3, disregulated 
cytokine and inflammatory mediator levels4,  quality and quantity of local inflammatory 
and immunological reactions to the bacterial challenge5 and alterations in host defense cell 
functions6 could attribute to the presentation of AgP. Several studies support the hypothesis 
that  genetic  variations  in  host  response contribute  to  the multi-factorial  background of 
AgP.  7,8,9 Numerous  candidate  genes  of  AgP  that  are  involved  in  immunity  and 
inflammation are under consideration. However, the immunopathogenic mechanism that 
surrounds this disorder is not thoroughly understood. 
1
Recognition of invading pathogens by the innate immune system is an essential 
pre-requisite for triggering inflammatory response and developing acquired immunity. The 
immune system is traditionally divided into innate and adaptive components.  The main 
distinction between the innate and adaptive immune systems lies in the mechanisms and 
receptors used for the immune recognition. The adaptive system is organized around two 
classes of specialized cells, T cells and B cells. Their receptors are generated somatically 
during development that endows each lymphocyte  with a structurally unique receptor10. 
The  innate  immune  recognition  is  mediated  by  germ-line-encoded  receptors,  and  the 
specificity of each receptor is genetically predetermined. The innate immune cells detect 
invading pathogens primarily through an array of pattern-recognition receptor.11 
Toll-like  receptors  (TLRs)  are  pattern-recognition  receptors  that  mediate 
intracellular signaling and antimicrobial responses upon recognition of conserved pathogen 
associated molecular patterns (PAMP) of microorganisms, and play a major role in innate 
immunity.12,13 TLRs form an important and potentially controllable checkpoint for a limited 
number of PAMPs derived from a large number of different bacterial species. Because the 
specificity  of  Toll-like  receptors  (and other  innate  immune  receptors)  cannot  easily  be 
changed in the course of evolution, these receptors recognize molecules that are constantly 
associated with threats (i.e. pathogen or cell stress) and are highly specific. PAMPs that 
meet  this  requirement  are  usually  critical  to  the  pathogen's  function  and  cannot  be 
eliminated  or  changed through mutation;  they are  said  to  be  evolutionarily  conserved. 
Some  of  the  PAMPs  associated  with  periodontal  bacteria  include  bacterial 
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lipopolysaccharide (LPS), fimbriae, lipoproteins and bacterial DNA.14  TLRs lack memory, 
which is characteristic to the innate immune system.
The Toll-like receptor cytoplasmic domains are homologous, but the extracellular 
domains  differ  and are  characterized  by the frequency of leucine-rich repeats.14 TLRs 
together  with  the  Interleukin-1  receptors  form  a  receptor  superfamily,  known  as  the 
"Interleukin-1 Receptor/Toll-Like Receptor Superfamily"; all members of this family have 
in common a so-called TIR (Toll-IL-1 receptor) domain. Three subgroups of TIR domains 
exist.  Proteins  with  subgroup  1  TIR  domains  are  receptors  for  interleukins  that  are 
produced  by  macrophages,  monocytes  and  dendritic  cells  and  all  have  extracellular 
Immunoglobulin (Ig) domains. Proteins with subgroup 2 TIR domains are classical TLRs, 
and  bind  directly  or  indirectly  to  molecules  of  microbial  origin.  A  third  subgroup  of 
proteins containing TIR domains consists of adaptor proteins that are exclusively cytosolic 
and mediate signaling from proteins of subgroups 1 and 2.
TLRs are believed to function as dimers. Though most TLRs appear to function as 
homodimers,  TLR2  forms  heterodimers  with  TLR1  or  TLR6,  each  dimer  having  a 
different ligand specificity. TLRs can be classified according to the types of ligands that 
they recognize. For example, TLR-1 recognizes triacyl lipopeptides. Lipid-based structures 
are recognized by TLR-2 and TLR-4.  Viral and/or bacterial nucleic acids are recognized 
by  TLR-3,  TLR-7,  TLR-8,  and  TLR-9; the  flagellin  and  peptidoglycan  ligands  are 
recognized by TLR-5 and TLR-6, respectively.15
TLRs may also depend on other co-receptors for full ligand sensitivity, such as in 
the case of TLR4's recognition of LPS, which requires MD-2. CD14 and LPS Binding 
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Protein (LBP) are known to facilitate the presentation of LPS to MD-2. LPS acts as a 
potent  stimulus  to  a  variety  of  host  cells  via  LPS-binding  protein  (LBP),  and  CD14 
pathway, which subsequently results in the expression of proinflammatory cytokines and 
amplifies the related host immune response in periodontal diseases. Like TLRs, the CD14 
receptor is considered as a key component of the innate immune system. Although TLRs 
are specific for bacterial species, the CD14 is a coreceptor of TLRs for gram-positive and 
gram-negative bacteria. Binding of bacterial cell wall component such as LPS to soluble 
CD14 causes activation of signalling via TLR4 in antigen-presenting cells,  resulting in 
secretion of interleukin- 12 from these cells.
CD14, which is present in plasma as a soluble form or on the monocyte cell surface 
as  a  glycosylphosphatidylinositol  (GPI)-anchored  50-KD  protein,  binds  to  LPS  and 
facilitates  its  signaling.  LPS-activated  monocytes  produce  proinflammatory  cytokines, 
such  as  tumor  necrosis  factor  α,  interleukin-1,  interleukin-6,  and  growth  factors16. 
Although  LPS  responses  are  detectable  without  CD14,  CD14  is  indispensable  for  the 
activation of the TRAM-TRIF pathway by TLR4/MD-2 (Fig. 1).17 
4
 
Fig  1.  CD  14-  dependent  and  independent  pathways.  CD  14  is  required  for  the 
activation of the TRAM-TRIF pathway by TLR4/MD-218
In  mammals,  TLR  activation  results  in  the  engagement  of  a  set  of  adaptor 
molecules, which include myeloid differentiation factor-88 (MyD88), Toll- IL-1 receptor 
(TIR) Toll-interleukin 1 receptor domain-containing adaptor protein (TIRAP/MAL), Toll 
receptor-associated  activator  of  interferon  (TRIF),  Toll  receptor-associated  molecule 
(TRAM), IL-1 receptor-associated kinase (IRAK), and TNF receptor-associated factor 6 
(TRAF6)  and  factor3  (TRAF3).  TLR  signaling  has  two  major  pathways:  MyD88-
dependent and -independent/TRIF-dependent pathways. MyD88-dependent signaling is a 
nuclear  factor  (NF)-κB activation  signal  and  is  essential  for  proinflammatory  cytokine 
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production  through  all  TLRs  but  TLR3.  On  the  other  hand,  the  MyD88-
independent/TRIFdependent signal induces delayed NF-κB activation and type-I interferon 
(IFN) production (Figs. 2,3).18
Fig. 2. Toll-like receptor 1 (TLR1), TLR2, TLR4, TLR5, and TLR6 signaling.  TLR 
signaling  has  myeloid  differentiation  factor-88  (MyD88)-  dependent  and 
-independent/ (TRIF)-dependent pathways. The MyD88-dependent signal is a nuclear 
factor  (NF)-κB  activation  signal  and  is  essential  for  inflammatory  cytokine 
production through all TLRs. On the other hand, the MyD88- independent/TRIF-
dependent signal delays NF-κB activation and induces type-I interferon (IFN).  LPS, 
lipopolysaccharide;  IRF3;  IF regulatory factor-3.  A46R, which is  a  vaccinia virus 
protein, sequesters TRAM, TRIF, TIRAP, and MyD8818
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Fig.  3.  TLR3,  TLR7,  and TLR8 or TLR9 signaling.  TLR3 signals through TRIF. 
TLR7 and TLR9 signals induce type 1 IFN through IRF7.  dsRNA, doublestranded 
RNA;  ssRNA,  singlestranded  RNA.  NS3/4A,  which  is  a  hepatitis  C  virus 
protein,degrades TRIF18
Through Recognition of pathogens and their products, TLRs activate nuclear factor 
kappa-light-chain-enhancer of activated B cells (NF-κB) , which is a protein complex that 
acts as a transcription factor. NF-κB is found in almost all animal cell types and is involved 
in  cellular  responses  to  stimuli  such  as  stress,  cytokines,  free  radicals,  ultraviolet 
irradiation,  oxidized  LDL,  and  bacterial  or  viral  antigens.  The  activation  results  in 
synthesis  and  release  of  cytokines  and  chemokines,  arachidonic  acid  molecules,  and 
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generation of reactive oxygen metabolites that are associated with tissue destructive events 
in periodontal  tissues.15 Cytokines that are produced in response to LPS-induced TLR 
activation play an important role in the regulation of host defence mechanisms against oral 
pathogens, as well as in host- mediated periodontal tissue destruction if inappropriately 
expressed. To date there are 10 Toll like receptors identified in humans that respond to 
distinctive PAMPs19.  Table  1 lists  the toll  like receptors,  their  ligands,  ligand location, 
adaptors, location and cell types. 
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Table  1.  Human Toll-Like  Receptors  1-10.  Lists  of  toll  like  receptors  1-10,  their 
ligands, ligand location, adaptors, location and cell types. 15
Receptor Ligands Ligand Location Adaptors Location Cell Type
TLR 1 Multiple triacyl 
lipopeptides
Bacteria MyD88/M
AL
Cell surface • Monocytes/ 
macrophages
• Dendritic cells
• B lymphocytes
TLR 2 Multiple glycolipids
Multiple 
lipopeptides
Multiple 
lipoproteins
Lipoteichoic acid
Bacteria
Bacteria
Bacteria
Bacteria
MyD88/M
AL
Cell surface • Monocytes/ 
macrophages
• Dendritic cells
• Mast cells
TLR3 Double stranded 
RNA
Viruses TRIF Cell 
compartment
• Dendritic cells
• B lymphocytes
TLR4 Lipopolysaccharide
Heat shock proteins
Fibrinogen
Hyaluronic acid 
fragments
Heparin sulfate 
fragments
Gram – bacteria
Bacteria and 
host cells
Host cells
Host cells
Host cells
MyD88/
MAL/
TRIF/
TRAM
Cell surface • Monocytes/ 
macrophages
• Dendritic cells
• Mast cells
• Intestinal 
epithelium
TLR5 Flagellin Bacteria MyD88 Cell surface • Monocytes/ 
macrophages
• Dendritic cells
• Intestinal 
epithelium
TLR6 Multiple diacyl 
lipopeptides
Mycoplasma MyD88/M
AL
Cell surface • Monocytes/ 
mcrophages
• Mast cells
• B lynphocytes
TLR7 Imidazoguinoline
Loxoribine 
(guanosine 
analogue)
Bropirimine
Single stranded 
RNA
Small synthetic 
compounds
MyD88 Cell 
compartment
• Monocytes/macr
ophages
• Dendritic cells
• B lymphocytes
TLR8 Small synthetic 
compounds; single 
stranded RNA
MyD88 Cell 
compartment
• Monocytes/ 
macrophages
• Dendritic cells
• Mast cells
TLR9 Unmethylated CpG 
DNA
Bacteria MyD88 Cell 
compartment
• Monocytes/ 
macrophages
• Dendritic cells
• B lymphocytes
TLR 10 Unknown Unknown Unknown Cell surface • Monocytes/ 
macrophages
• B lymphocytes
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For this study, we specifically looked at TLR 2, 4, 9 and CD 14. It should be noted 
that  cell  surface  Toll  like  receptors  (TLR  2,4)  seem  to  recognize  microbial  products 
whereas intracellular Toll-like receptors (TLR 9) recognize nucleic acids.14 
TLR  4  was  the  first  Toll  to  be  described  in  humans.20 It  recognizes 
lipopolysaccharides  (LPS)  derived  from  many  pathogens  including  Aggregatibacter 
actinomycetemcomitans (A.a.) or Porphyromonas gingivalis (P.g.), the main pathogens in 
AgP. 21,22  Accordingly, it was shown that A.a. stimulates the TLR4-dependent production 
of  several  cytokines23 and  the  optimal  interferon-g  (IFN-g)  response  induced  by  A.a.- 
stimulated dentridic cells was also TLR4 dependent. 
Polymorphism in the coding region of the TLR4 (A896G) induces an amino acid 
substitutions of Asp 299 Gly which affect the extracellular domain of the TLR4 receptor. 
The TLR4(A896G) polymorphism results in reduction in cell surface expression of TLR4 
and  subsequent  disruption  of  LPS  mediated  signaling  and  can  modify  response  to 
endotoxin,24 hence  associated  with  increased  susceptibility  to  gram-negative  infections. 
The role of 299Gly in infectious diseases is explained by TLR4 hyporesponsiveness to its 
ligands, mainly LPS and respiratory syncytial virus (RSV), caused by these variants25. The 
replacement  of  the  conserved  Asp  with  Gly  at  position  299  has  been  reported  to 
theoretically cause disruption of the α-helical protein structure, resulting in an extended β-
strain, which is less functional26. Furthermore, epithelial airway cell lines transfected with 
299Gly  promoted  a  lack  of  surface  TLR4 expression  at  the  time  of  stimulation  when 
compared  with  299Asp transfected  cells,  and  also,  those variants  were responsible  for 
reduced nuclear factor κB (NF-κB) activity27. Activated TLR4 was demonstrated to induce 
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expression of proinflammatory cytokines (via NF-κB pathway), many of which have been 
implicated  in  Type  II  diabetes  mellitus.28 Therefore,  evidence  demonstrates  that 
impairment of inflammatory signal transduction by 299Asp could increase the risk of acute 
bacterial infection but decrease risk of chronic diseases, type II diabetes. 
Previous  studies  have  shown that  the Asp 299Gly variant  not  only impairs  the 
inflammatory response and is associated with reduced plasma C-reactive protein levels but, 
in  parallel,  is  linked with  decreased  angiographic  coronary artery disease  and diabetes 
prevalence.29 Many  studies  have  related  the  299Gly  variant  polymorphism  with  an 
increased risk of septic shock30, Gram-negative infections31, severe malaria32, respiratory 
syncytial  virus  (RSV)  infection33,  expressed  by  tumor  cells  that  promote  tumor  cell 
proliferation and survival, as well as invasion and metastasis, development of atopy and 
asthma34 and premature birth associated with infection35. 
TLR2 is a membrane bound receptor that recognizes the widest range of PAMPs 
such as lipoproteins, glycopeptides, peptidoglycan, lipoteicoic acid, and lipoarabinomanan. 
It is also involved in  P.g.  fimbriae- and LPS-mediated signalling36.  This large range is 
covered by the ability of TLR2 to build a heterodimer with TLR1 or TLR6. The receptor is 
expressed predominantly in hematopoietic system-derived cells that are involved in first-
line host defense, including monocytes, macrophages, dendritic cells, polymorphonuclear 
leukocytes, B-cells, T-cells as well as regulatory T cells (CD4, CD25) and epithelial cells.
The  SNP,  TLR2  (G2408A),  is  located  within  the  intracellular  portion  of  the 
receptor resulting in an amino acid exchange, Arg753 to Gln. Previous work has suggested 
the association of TLR2 (G2408A) with other atopic disease and showed that all patients 
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with TLR2 (G2408A) allele have higher levels of total serum immunoglobulin E (IgE) and 
super-antigenspecific IgE37. 
Human  alveolar  epithelial  cells  type  II  and  alveolar  macrophages  express  both 
TLR2  mRNA  and  protein;  this  plays  an  essential  role  in  TLR2  signaling  during  the 
inflammatory response of the alveolus  to control  the localized  inflammatory reaction38. 
Thus,  TLR2  is  likely  to  play  an  important  role  in  the  etiology  of  inflammatory  lung 
diseases. Studies have shown that Arg 753Gln impairs TLR 2 signaling and is associated 
with susceptibility to tuberculosis39, Lyme’s disease40, but reduced susceptibility to asthma 
and allergy in farmer’s children41.
Toll-like  receptor  9  recognizes  unmethylated  CpG (Cytosine  phosphate  guanine 
sites  within  DNA42 molecules.  They are  regions  of  DNA where  a  cytosine  nucleotide 
occurs next to a guanine nucleotide in the linear  sequence of bases.  It  also recognizes 
DNAs of  periodontal  pathogens such as  A.  actinomycetemcomitans.,  P.  gingivalis and 
Peptostreptococcus  micros.43,44 TLR9  is  expressed  by  numerous  cells  of  the  immune 
system such as  dendritic  cells,  B  lymphocytes  and  natural  killer  (NK) cells.  TLR9 is 
expressed intracellularly,  within the endosomal compartments and functions to alert  the 
immune system of viral and bacterial infections. In humans it is preferentially expressed by 
plasmacytoid dendritic cells (PDC) and B cells (reviewed in Ref. 21). TLR9  signals 
lead  to  activation  of  the  cells  initiating  pro-inflammatory  reactions  that  result  in  the 
production of cytokines such as type-I interferon, IL-1, IL-6, TNF-α and IL-12. The net 
effect  of  TLR9 activation  is  the  differentiation  of  Th1 cells  and  the  induction  of  IgG 
isotype switching and Ab secretion. Studies have shown that TLR9 stimulation promotes 
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the accumulation and activation of hepatic CD4 cells by Kupffer cell and that  TLR9 to be 
involved in the pathogenesis of human hepatitis.45
SNP  of  TLR  9  (T1486C)  is  located  in  the  promoter  region  of  the  gene,  and 
previous studies showed that a potential binding site for transcription factor exists in that 
region  which can  affect  transcription  regulation  and gene expression46.  Indeed,  the  TT 
allelic variant sequence at C1486T showed a significantly higher promoter activity than the 
CC allelic  variant  sequence47. Single  nucleotide polymorphism(SNP) in  this  region has 
been shown to be associated with atopic diseases such as eczema47 and systemic lupus48
The  gene  for  CD14  has  been  localized  to  chromosome  5q31-33  and  (C260T) 
polymorphism in this region has been shown to be associated with total and specific IgE 
level49. Upon binding with the soluble CD14 receptor, LPS also activates endothelial cells 
to  express  surface  receptors  for  lymphocytes  and macrophages,  and  stimulates  smooth 
muscle cells to proliferate and migrate; the events representing atherogenesis50. Previous 
studies showed the TT genotype is correlated with a higher concentration of soluble CD14 
in serum and a higher density of membrane-anchored CD14 on monocytes51 and associated 
with atherosclerotic or macroangiopathic stroke. 52  
Gingival  fibroblasts  are  the major  constituents  of  periodontal  connective  tissue. 
They  maintain  gingival  tissue  integrity  by  regulating  collagen  and  proteoglycan 
metabolism. Human gingival fibroblasts constituitively express mRNA of TLR 2, 4 and 
953,54 and CD14. DNA microarray analysis demonstrated increased expression of Toll-like 
receptor 2, 4 and CD14 in human gingival fibroblasts in periodontitis patients compared to 
periodontally-healthy individuals.55 Interestingly, upon in vitro stimulation by P.gingivalis 
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lipopolysaccharide, human gingival fibroblasts showed increased expression of Toll-like 
receptor 2, 4 and CD14.54 Another study showed that TLR-9 is expressed in significantly 
higher frequency in the epithelial  cell  layers  in chronic periodontitis  patients  compared 
with healthy samples.56 Based on these studies it can be suggested that TLR activation may 
have a critical  role in amplifying the inflammatory reaction in periodontal  tissues. The 
polymorphisms  in  toll-like  receptor  and  CD14  genes  are  implicated  in  the  host 
susceptibility to periodontal disease57 and there are some suggestions that aggressive and 
chronic forms of the disease share the same genetic predisposition.69 
The role of CD 14 in AgP as well as the function of TLR2, 4 and 9 in cytokine 
activation implies that genes coding for these proteins could be candidate genes for an 
increased  periodontitis  risk.  We hypothesized  a  priori  that  the polymorphisms  in  these 
PRRs might  modify  the  relative  risk  for  development  of  AgP.  Several  studies  on  the 
association of single-nucleotide polymorphisms (SNPs) in the TLR2, 4, and CD 14 with 
periodontitis  have  been  performed,  with  inconsistent  results  in  different  populations. 
58,59,60,61,62,63 and no studies have investigated the association of TLR 9 SNP with periodontal 
disease to date. An individual’s race plays a major role determining the genetic background 
of  an  individual,  and  discrepancies  in  studies  regarding  polymorphisms  in  PRRs  and 
periodontal disease association can partly be explained by racial differences.  Thus, the aim 
of  this  study  was  to  evaluate  the  role  of  SNPs  in  TLR2  (G2408A),  TLR4  (A896G), 
TLR9(T1486C) and CD 14 (C260T) in patients with AgP compared with healthy controls 
in African American population.
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CHAPTER 2 Methods
Patient and control subjects were previously recruited to be participants in studies 
involving  genetic  analysis  to  elucidate  the  role  of  genetic  background  in  aggressive 
periodontal  disease.  The protocol  for genetic  analysis  was approved by an institutional 
review  board  and  all  participants  provided  written  informed  consent  prior  to  their 
enrollment into the study. 
60 African American aggressive periodontitis subjects are enrolled in this study. 
The LAP (25) group consists of subjects less than 30 years old, with attachment loss of at 
least 5mm affecting first molars and incisors. The GAP (50) group consists of the same 
criteria except the affected sites involve at least 3 permanent teeth other than first molars 
and incisors. 
The periodontally healthy (NP) control group comprised a total of 70 unrelated, age 
matched,  African  American  individuals  without  aggressive  or  any  other  form  of 
periodontitis.  The  absence  of  periodontal  disease  was  documented  according  to  the 
following criteria: No sites with probing depth ≥ 3mm.
Individuals who had or have any systemic problems were excluded from the study. 
The smoking status was classified as current, former and non-smokers. Subjects who quit 
smoking for 5 years  or more  were assigned to non-smoker  group and former smokers 
group included those who had quit smoking within 5 years.
Blood samples  were collected from the antecubital  vein of the forearm of each 
individual by a properly trained phlebotomist.  The buffy coats were stored at -70ºC for 
future tests. Whole genomic DNA was isolated from 200µl of buffy coats using a DNA 
extraction Kit from QIAGEN following the manufacturer’s instructions.
Genotyping were performed on the following  genes:  TLR 2, 4, 9, and CD 14. 
TLR2(G2408A)  (NCBI  SNP  CLUSTER  ID:  rs5743708),  TLR4(A896G)  (NCBI  SNP 
CLUSTER ID: rs4986790), TLR9 (T1486C) (NCBI SNP CLUSTER ID: rs187084) and 
CD14 (C260T) (NCBI SNP CLUSTER ID: rs2569190).
All  screening  methods  were  carried  out  with  TaqMan  SNP  Assays  (Applied 
Biosystems)  using  Real  Time  thermocycler  AB  7500  (Applied  Biosystems).  Specific 
primers were determined using ABI PRISM Sequence Detection System (SDS) software 
following  published  protocols.64,65,66,67,68 Positive  controls  with  known  genotypes  and 
negative control without DNA template were included in each PCR run. To further validate 
the  results  obtained  from  real  time  analysis,  PCR-RFLP  analyses  were  performed  on 
selected samples. 
Thorough  statistical  power  analysis  was  carried  out  in  the  program Power  and 
precision version 2, based on the guidelines as follows: 1) 80% power, and alpha of 0.05. 
2)  Chi  squared goodness of  fit  test.  3)  Allele  frequencies  from published studies.  The 
power analysis implies that noteworthy differences could be detected between the study 
samples in this pilot study and sample size is large enough for future power analysis. The 
chi-square test was performed to determine the significance of the difference in genotype 
frequency  of  TLR  2,  4,  9  and  CD14  between  healthy  controls  and  patients  with 
periodontitis. Fisher’s exact test was performed to compare allele carriage and frequency. 
Within diseased group, we investigated whether SNPs were related to disease severity by 
step-wise regression adjusted for age, gender, and smoking status. The difference between 
data sets with a probability of <0.05 was regarded as statistically significant.  
CHAPTER 3 Results
The characteristics of the study population based on smoking status is shown in 
Table  2.  There  was  a  significant  difference  between  diseased-  versus  healthy  groups 
regarding smoking and age and therefore all statistical analyses were adjusted for these 
parameters. 
Specific genotypes for TLR2 (G2408A), TLR4 (A896G), TLR9(T1486C) and CD 
14 (C260T) are presented in Table 3. In the localized aggressive periodontitis group TLR 
9(T1468C) is present in 16% of patients with the CC genotype, 32% with CT genotype and 
52% with TT genotype. Generalized aggressive periodontitis group has TLR 9(T1468C) 
presence in 10% of the patients with the CC genotype, 42% with the CT genotype and 48% 
with the TT genotype. The control group has 7.02%, 75.44% and 17.54% of patients in the 
CC,  CT  and  TT  genotype  groups  respectively.  The  TT  genotype  of  TLR9(T1486C) 
polymorphism  was  present  significantly  more  frequently  in  aggressive  periodontitis 
patients  compared  to  control  group.  (p<0.0001)  Distribution  of  genotypes  was  not 
statistically different among groups for TLR 2, 4, and CD 14 polymorphisms. (Table 3).  
Further analyses demonstrated that individuals expressing C allele of the TLR9(T1468C) 
SNP (CC&CT) were more frequently found in healthy group (82.46%) compared to all the 
diseased groups (48.00% LAP, 52.00% GAP) after adjusting for age, gender, and smoking 
status (p<0.0001)(Table 4). Genotyping was performed on a real-time PCR and the results 
were  further  confirmed  by  RFLP  analyses  on  selected  samples  and  Fig  4  shows  a 
representative agarose gel showing different genotypes in CD14 receptor. (Fig 4)
Smoking 
Status
LAP n 
(%)
NP n 
(%)
GAP n (%)
Former 
smoker
0
0.00
8
14.55
8
16.00
Never smoker 22
88.00
40
72.73
18
36.00
Undetermined 0
0.00
1
1.82
0
0.00
Current 
smoker
3
12.00
6
10.91
24
48.00
Table 2. Smoking data among different diseased groups. The distribution of smokers 
was significantly different between groups (p<0.0001)
Polymorphisms Genotype NP n (%) GAP n (%) LAP n (%)
TLR2(G2408A) GG
GA
AA
51 (91.07) 
3 (5.36) 
2 (3.57)
49 (98)
1 (2)
0 (0)
25 (100)
0 (0)
0 (0)
TLR4(A896G) AA
AG
GG
44 (83.02)
7 (13.21)
2 (3.77)
18 (75.00)
6 (25)
0 (0)
41 (89.13)
3 (6.52)
2 (4.35)
TLR9 (T1486C) CC
CT
TT
4 (7.02)
43 (75.44)*
10 (17.54)*
5 (10)
21 (42)
24 (48)
4 (16)
8 (32)
13 (52)
CD14(C260T) TT
CT
CC
4 (8.00)
36 (72.00)
10 (20.00)
5 (13.89)
22 (61.11)
9 (25)
3 (15)
15 (75)
2 (10) 
Table 3. Distribution of TLR2, 4, 9, and CD14 Genotypes.  There was no significant 
difference  in  genotype  distribution  between  groups  for  TLR  2,  4  and  CD  14. 
Frequency of genotypes were significantly different for TLR9 polymorphism between 
diseased versus control group (p<0.001). 
Genotypes NP n(%) GAP 
n(%)
LAP 
n(%)
CC & CT 47
(82.46)*
26
(52.00)
12
(48.00)
TT 10
(17.54)*
24
(48.00)
13
(52.00)
Table  4.  TLR9  (T1486C)  polymorphism  CC&CT  versus  TT.  The  frequency  of 
individuals  expressing  the  C  allele  of  TLR9  gene  polymorphism  (CC&CT)  was 
significantly  higher  in  the  control  group  (82.46%)  compared  to  all  the  diseased 
groups  (45.07%  CP,  48.00%  LAP,  52.00%  GAP)  (p<0.0001).  *adjusted  for  age, 
gender, and smoking status
CHAPTER 4 Discussion
Periodontitis is a multifactorial polymicrobial infection initiated by the presence of 
Gram-negative bacteria, which accumulates in the gingival crevice region.69 The presence 
of periodontopathogenic bacteria leads to the establishment of an inflammatory process in 
periodontal  tissues, which leads to destruction of periodontal  ligament and the adjacent 
supporting bone, causing tooth loss.70 Periodontal destruction is considered as a result of 
the response of a susceptible host to bacterial challenge. The host’s response to infection 
depends on the virulence of the pathogen, and is influenced by host response and genetic 
factors.71 For this reason, genes involved in the individual immune response are considered 
as susceptibility genes for periodontitis. Recent studies on the pathogenesis of periodontitis 
have focused their attention on the topic of molecular events that lead to the inflammatory 
response through the TLR family. TLR polymorphisms can modify host susceptibility by 
altering the inflammatory and immune response to microbial infection. The objective of 
this study was to determine the frequency of TLR-2, 4, and 9 and CD 14 polymorphisms in 
aggressive periodontitis and periodontally healthy patients. 
The genetic impact on the etiology of both aggressive and chronic periodontitis was 
demonstrated in previous studies. 72  Although, it could be shown that a similar amount of 
immune cells are available in patients with aggressive and chronic periodontitis compared 
with healthy controls, the functional activity of these cells is altered.73 As a potential cause 
of  the observed alteration  in  immunological  activity,  genetic  differences  are  discussed. 
Therefore,  inflammatory  genes  are  regarded  as  susceptibility  genes  for  chronic  and 
aggressive  periodontitis.  In  this  study,  polymorphisms  of  TLR 2,4,  9  and   CD14  are 
evaluated for susceptibility to aggressive periodontal disease.   
From  this  current  study  using  African  American  population,  in  the  localized 
aggressive periodontitis group TLR 9(T1468C) was present in 16% of patients with the CC 
genotype,  32% with CT genotype  and 52% with TT genotype.  Generalized  aggressive 
periodontitis  group has TLR 9(T1468C)  presence in 10% of the patients  with the CC 
genotype, 42% with the CT genotype and 48% with the TT genotype. The control group 
has  7.02%,  75.44% and  17.54% of  patients  in  the  CC,  CT and  TT  genotype  groups 
respectively. The TT genotype of TLR9(T1486C) polymorphism was present significantly 
more frequently in aggressive periodontitis patients compared to control group (p<0.0001). 
Further analyses demonstrated that individuals expressing C allele of the TLR9(T1468C) 
SNP (CC&CT) were more frequently found in healthy group (82.46%) compared to all the 
diseased groups (48.00% LAP, 52.00% GAP) after adjusting for age, gender, and smoking 
status  (p<0.0001)  No  statistically  significant  differences  were  noted  aggressive 
periodontitis subjects and the control group when comparing genotype frequency for TLR2 
(G2408A), TLR4 (A896G), and CD 14 (C260T). 
Previous studies by Schulz 200874 evaluated links between genetic polymorphisms 
of CD14 and TLR4 and risk markers of periodontitis, they utilized one hundred and thirty-
three periodontitis patients (chronic: n = 60, aggressive: n = 73) and 80 healthy controls. 
Polymorphisms in CD14 c.-159C>T and in TLR4 Asp299Gly, Thr399Ile were determined 
by restriction fragment length polymorphism analyses. Subgingival bacterial colonization 
was  analysed  molecularbiologically  using  the  micro-Ident  test.  The  study  found  that 
Prevotella intermedia occurred less frequently in individuals positive for the TT genotype 
of CD14 in bivariate  analysis  (odds ratio = 0.36%, confidence interval:  0.14-0.91, P = 
0.045).  They  also  found  no  significant  association  with  chronic  and  or  aggressive 
periodontitis  and polymorphisms  in  CD14 and TLR4 in German periodontitis  patients, 
which is consistent with our results. 
In  another  study  by  Noack  200875 looking  at  German  population  supports  the 
findings  of  Schultz  2008.  The  study  looked  at  one  hundred  and  eleven  patients  with 
aggressive periodontitis and 80 periodontally healthy controls for their genotypes for four 
functional variants in the TLR4 gene (c.896A>G and c.1196C>T). The results found no 
statistical differences in genotype and allele frequencies within the four variants between 
the groups. All study subjects were further classified into carriers and non-carriers of at 
least one variant of both genes. The logistic regression analysis adjusted for gender and 
smoking showed no association between carrier status of at least one variant of both genes 
and periodontal status (OR=1.41, 95% CI: 0.43-4.70). 
Zhu 200876 conducted a study to investigate the relationship between TLRs 2 and 4 
gene  polymorphisms  and  periodontitis  in  a  Chinese  population.  Subjects  include  forty 
patients with generalized aggressive periodontitis, 50 patients with chronic periodontitis, 
and 100 periodontally healthy controls.  TLRs 2 and 4 genes were analyzed by polymerase 
chain  reaction-restriction  fragment  length  polymorphism  (PCR-RFLP)  with  respective 
restriction endonucleases. The alleles were detected by polyacrylamide gel electrophoresis 
and visualized with ethidium bromide. The result of the study finds heterozygosity for the 
TLR2 Arg677Trp polymorphism in all subjects. The TLR2 Arg753Gln mutant allele was 
not found in periodontitis patients, while a heterozygous frequency of 6% (6 of 100) was 
detected  in  the controls.  The TLR4 Asp299Gly and Thr399Ile  mutant  alleles  were not 
found in any of the subjects. From the date of this study, we can gather that the prevalence 
of TLR2 Arp677Trp polymorphism seemed to be higher than that of TLR4 Asp299Gly and 
Thr399Ile polymorphisms in the Chinese population, but neither TLR 2 or 4 polymorphism 
may not be associated with aggressive or chronic periodontitis.
Emingil 200777 again looked at TLR2 and TLR4 gene polymorphisms as they are 
related  to  susceptibility  to  generalized  aggressive  periodontitis  (GAgP)  in  a  Turkish 
population.  245  subjects  were  included  in  the  present  study  with  GAgP  and  155 
periodontally healthy subjects. The TLR2 gene Arg753Gln and Arg677Trp polymorphisms 
and  TLR4  gene  Asp299Gly  and  Thr399Ile  polymorphisms  were  determined  by  the 
polymerase chain reaction-restriction fragment length polymorphism method. They found 
no  significant  difference in  the  distribution  of  TLR2  and  TLR4  genotypes  and  allele 
frequencies between GAgP patients and healthy subjects (P > 0.05). 
Some studies, however were able to show that TLR polymorphisms have an impact 
to the presence of aggressive periodontitis. James 200778 conducted a study to determine 
whether there is an association between the frequency of functional polymorphisms in the 
toll-like receptor 4 (TLR4) and cluster differentiation 14 (CD14) genes and periodontitis. 
Genotyping for the TLR4 single-nucleotide polymorphisms (SNPs) Asp299Gly, Thr399Ile 
and  the  CD14  SNPs  -159  and  -1359  was  completed  for  73  subjects  with  aggressive 
periodontitis (AgP; 28 males, 45 females) and 95 males with chronic periodontitis (CP). 
The TLR4 and CD14 polymorphisms were determined using SNaPshot primer extension 
with  capillary  electrophoresis.  The  TLR4  Asp299Gly  AG  genotype  was  present  in  a 
significantly (p=0.026) lower proportion of AgP subjects (5.5%) compared with control 
subjects (16.3%). And AA genotype was significantly (p=0.026) higher in AgP subjects 
(94.5%)  versus  the  control  subjects  (83.7%).  The  No  differences  were  found  in  the 
prevalence of the TLR4 Asp299Gly genotype between the CP (18.9%) and control group 
(17%). In addition, there was no difference in the distribution of the CD14 polymorphisms 
in either the AgP or CP populations studied compared with controls. This study finds that 
the Asp299Gly TLR4 gene polymorphism is associated with a decreased risk of AgP but 
not  CP  in  West  European  Caucasians.  Promoter  polymorphisms  of  the  CD14  gene, 
however, did not influence susceptibility to inflammatory periodontitis in the population.
Another  study  by  Schroder  200579 recruited  197  individuals  suffering  from 
generalized  periodontitis,  they were then screened for  the  presence  of  Asp299Gly and 
Thr399Ile of TLR-4 as well as Arg753Gln of TLR-2 in comparison to matched controls. 
Single-nucleotide  polymorphisms  (SNPs)  of  TLR-4 were elevated  among patients  with 
generalized chronic periodontitis (odd's ratio 3.650, 95% CI 1.573-8.467, P < or = 0.0001), 
while no difference was observed for TLR-2. TLR-4 SNPs were correlated with chronic 
periodontitis  (odd's  ratio  5.562,  95% CI  2.199-14.04,  P  <  or  =  0.0001),  but  not  with 
aggressive periodontitis. These data demonstrate that genetic variants of TLR-4 may act as 
risk factors for the development of generalized chronic periodontitis in German population.
As the effect of various TLR polymorphisms on patient susceptibility and disease 
progression becomes better  understood, genotypic  profile will  comprise an increasingly 
important  factor in the consideration of various therapeutic  options.  Future studies will 
continue to improve our understanding of the relationships among TLR signaling, genetic 
polymorphism and the pathogenesis of aggressive periodontitis, revealing new approaches 
to  modulate  this  system in ways  that  favorably affect  disease mechanisms  and clinical 
settings.
CHAPTER 5 Conclusion
Increasing number of reports indicate an association between toll-like receptors and 
disease  processes,  including  periodontal  disease.   Our  results  indicated  that   genetic 
variations at  the TLR-9 promoter region (T1486C) containing the C allele  (CC & CT) 
appear to confer resistance to periodontal destruction, while individuals homozygous for 
the  T  allele  were  more  susceptible  to  periodontal  destruction  when  compared  with  a 
periodontally healthy control group in an African American-population. Additionally, the 
present results indicate that general susceptibility to periodontitis is not associated with the 
genetic  background of  the  CD14,  TLR 2,  and TLR 4 polymorphisms.  SNP of  TLR 9 
(T1486C) is located in the promoter region of the gene, and previous studies showed that a 
potential binding site for transcription factor exists in that region which can affect gene 
expression. Many reports have demonstrated increased susceptibility to periodontitis with 
TLR4 and CD14 polymorphisms in different patient ethnicities.  Conversely, there are also 
reports  that  found  no  association  between  polymorphisms  in  toll-like  receptors  and 
periodontal  disease.   An  individual’s  race  plays  a  major  role  determining  the  genetic 
background of  an  individual,  and discrepancies  in  studies  regarding  polymorphisms  in 
PRRs and periodontal  disease association can partly be explained by racial  differences. 
This  is  the  first  study  that  investigated  a  potential  role  of  specific  polymorphisms  in 
periodontal disease susceptibility in an African-American population.  Additionally, this is 
the first study that investigated the role of TLR9 polymorphism in periodontal disease and 
showed  a  possible  association  of  specific  alleles  (TT)  of  TRL9  SNP  with  disease 
susceptibility.  For verification of the presented results,  prospective studies investigating 
larger cohorts should be conducted.  
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